Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 2/20 | 0.43 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | CASP7 | P55210 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26259566 | 0.78 | POLB (0.48) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL28308382 | 0.76 | CDC25A (0.48) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL23611339 | 0.75 | ALOX15 (0.43) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL26259720 | 0.73 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL16115007 | 0.72 | HTR1A (0.44) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL7747485 | 0.71 | MEN1 (0.42) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL1799678 | 0.71 | ALDH1A1 (0.63) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL11398832 | 0.70 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL345743 | 0.70 | POLB (0.34) | KDM4EALDH1A1HPGDPOLBNPC1 | |
| SCHEMBL12679742 | 0.70 | ADORA2A (0.54) | KDM4EALDH1A1HPGDPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604490-A | Chromen-5-one derivatives for use as fragrances | 奇华顿股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-3893673-A1 | COMPOSITIONS AND METHODS RELATED TO ANIONIC CANNABINOID MOLECULES | Natural Extraction Systems, LLC (US) | 2021-10-20 | — | — | EP | claimed |
| WO-2021041637-A1 | COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN GLYCEROL | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| WO-2020123809-A1 | COMPOSITIONS AND METHODS RELATED TO ANIONIC CANNABINOID MOLECULES | Natural Extraction Systems, LLC (US) | 2020-06-18 | — | — | WO | claimed |
| EP-1613313-B1 | 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-4,5]-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER | JANSSEN PHARMACEUTICA NV (BE) | 2007-06-06 | — | — | EP | claimed |
| EP-0099172-A1 | 6,7-Dihydro-7,7-disubstituted-khellins | THE UPJOHN COMPANY (US) | 1984-01-25 | — | — | EP | claimed |
| US-20260041621-A1 | CHROMEN-5-ONE DERIVATIVES FOR USE AS FRAGRANCES | GIVAUDAN SA (CH) | 2026-02-12 | — | — | US | disclosed |
| US-12545852-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-02-10 | — | — | US | disclosed |
| EP-4561997-A1 | CHROMEN-5-ONE DERIVATIVES FOR USE AS FRAGRANCES | Givaudan SA (CH) | 2025-06-04 | — | — | EP | disclosed |
| EP-4561997-A1 | CHROMEN-5-ONE DERIVATIVES FOR USE AS FRAGRANCES | Givaudan SA (CH) | 2025-06-04 | — | — | EP | disclosed |
| CN-115335374-B | GLP-1R modulating compounds | 吉利德科学公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119604490-A | Chromen-5-one derivatives for use as fragrances | 奇华顿股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119604490-A | Chromen-5-one derivatives for use as fragrances | 奇华顿股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-1131101-A1 | KHELLIN PREPARATION AND THE USE THEREOF FOR TOPICAL THERAPY | Röcken, Martin (DE) | 2001-09-12 | — | — | EP | disclosed |
| WO-2000030682-A1 | KHELLIN PREPARATION AND THE USE THEREOF FOR TOPICAL THERAPY | ROECKEN MARTIN (DE) | 2000-06-02 | — | — | WO | disclosed |
| EP-0670721-B1 | DRUG FOR TREATMENT AND PROPHYLAXIS OF BONE AND JOINT DISEASES | FRICKER CHRISTIAN (CH) | 1999-08-11 | — | — | EP | disclosed |
| EP-0885192-A1 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997027177-A2 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN-4-ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0670721-A1 | DRUG FOR TREATMENT AND PROPHYLAXIS OF BONE AND JOINT DISEASES | Fricker, Christian (CH) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995008992-A1 | DRUG FOR TREATMENT AND PROPHYLAXIS OF BONE AND JOINT DISEASES | FRICKER CHRISTIAN (CH) | 1995-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545852-B2 | Odorants and compositions comprising odorants | ENY2, CDY1; CDY1B, CHRM5 | KDM4E 1249/4885ALDH1A1 453/4885HPGD 2292/4885 |
| US-20260041621-A1 | CHROMEN-5-ONE DERIVATIVES FOR USE AS FRAGRANCES | CBR1, HTR1D, CBR3 | KDM4E 314/4885ALDH1A1 377/4885HPGD 2083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.